We’ve got a fresh wave of Strong Buy ratings, just for you:
-
SanDisk Corp (SNDK) — Up 2,200% in a year riding the AI wave
-
Gilead Sciences Inc (GILD) — Top-rated pharma giant with a $5B oncology bet
-
Penguin Solutions Inc (PENG) — Under-the-radar AI infrastructure play beating estimates
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Buffett's $114 Secret
In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account."
Today, that single, $114 investment would be worth over $15 million.
Your bank never told you about this.
Click Here to See How It Works
1. Gilead Sciences Inc (NASDAQ: GILD)
Gilead Sciences is a leading biopharma company behind some of the most important HIV and hepatitis treatments worldwide. Now, it's making a bold push into oncology with a $5B Tubulis acquisition — signaling a major new growth chapter ahead.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $140.00 — get current quote
Max 1-year forecast: $180.00
Why we're watching:
- Analyst support: GILD enjoys impressive coverage with 10 Strong Buy ratings, 2 Buy ratings, and 2 Hold ratings among 14 analysts we track, reflecting strong confidence in the company's direction. See the ratings
- Needham's Joseph Stringer (a top 1% rated analyst) reiterated a Buy rating with a $170 price target (suggesting over 20% potential upside), highlighting the company's robust pipeline and effective strategy.
- Industry ranking context: GILD is currently the 1st highest-rated stock in the General Drug Manufacturer industry, which has an Industry Rating of A. (Learn more about our Industry Ranking here.)
- Zen Rating highlights: As a Strong Buy stock, GILD ranks in the top 5% of tickers we track based on a sturdy 115-factor review.
- Component Grades: Looking at the Component Grades that make up that overall score, GILD earns impressive As for Financials and Value and Bs for Sentiment, Safety, and Momentum. See all 7 Zen Component Grades here
2. Penguin Solutions Inc (NASDAQ: PENG)
Penguin Solutions builds enterprise solutions across Advanced Computing, Integrated Memory, and Optimized Solutions. As enterprises, governments, and neocloud providers race to deploy AI factories, Penguin is emerging as a key player — especially with its MemoryAI™ CXL-based solutions powering AI inference workloads.
Zen Rating: B (Buy) — see full analysis
Recent Price: $25.73 — get current quote
Max 1-year forecast: $32.00
Why we're watching:
- Analyst support: PENG enjoys a perfect buy-side consensus with 2 Strong Buy and 1 Buy rating among 3 analysts, with zero Hold, Sell, or Strong Sell ratings. See the ratings
- Rosenblatt's Kevin Cassidy (a top 1% rated analyst) recently raised the price target to $32 following Q2 2026 earnings, highlighting that the company added five new AI/HPC customers including a Tier One financial institution deploying MemoryAI™ solutions.
- Stifel Nicolaus' Brian Chin (top 2%) maintained a Strong Buy rating with a $24 price target, recognizing the company's expanding customer base beyond hyperscalers as an important indicator of consistently profitable growth.
- Good guidance: Management raised full-year guidance to 7%-17% revenue growth following a Q2 beat, with EPS of $0.52 (beating estimates by 20.93%) demonstrating strong execution despite challenging market conditions.
- Industry ranking context: PENG is currently the 4th highest-rated stock in the Semiconductor industry, which has an Industry Rating of B.
- Zen Rating highlights: Buy (B) stocks average +19.88%/yr, meaning PENG is in a category of proven outperformers.
- Component Grades: Looking at the Component Grades that shape the overall score, PENG demonstrates several areas of strength, including an A for Value and Sentiment and a B for Financials, reflecting the company's attractive valuation and strong growth trajectory. See all 7 Zen Component Grades here
SanDisk develops storage devices and solutions built on NAND flash technology, from solid state drives to embedded and removable storage. The stock has skyrocketed over 2,200% in the past year as the AI boom fuels massive demand for memory solutions — and it's about to join the Nasdaq-100 Index on April 20, 2026.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $937.00 — get current quote
Max 1-year forecast: $1,000.00
Why we're watching:
- Analyst support: SNDK enjoys strong Wall Street backing with 9 Strong Buy ratings, 3 Buy ratings, and 4 Hold ratings among 16 analysts, delivering a Strong Buy consensus. See the ratings
- Cantor Fitzgerald's C.J. Muse (a top 2% rated analyst) recently maintained a Strong Buy rating with a $1,000 price target, representing 17.4% upside even after the massive rally.
- Bank of America's Wamsi Mohan (top 1%) set a $900 price target, while Citigroup's Asiya Merchant (top 1%) targeted $875, both maintaining Strong Buy ratings.
- Morgan Stanley's Joseph Moore (top 1%) and Jefferies' Blayne Curtis (top 1%) both highlighted the company's position as a pure-play NAND winner in the AI boom.
- SNDK is also part of our Zen Investor portfolio, where Editor-in-Chief Steve Reitmeister still rates SNDK a Strong Buy despite the fact that it’s already gained 70% since its addition to the portfolio. See more of the stocks in the portfolio here.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr, putting SNDK in the top tier of stocks we track based on a 115-factor review.
- Component Grades: Looking at the Component Grades that shape the overall rating, SNDK earns an A for Growth and Sentiment, and Bs for Momentum and Financials, reflecting the company's exceptional growth trajectory balanced against its rapid valuation expansion. See all 7 Zen Component Grades here
What to Do Next?